Skip to main content

Advertisement

Table 1 SRSF2 mutations in chronic myelomonocytic leukemia

From: SRSF2 mutations in myelodysplasia/myeloproliferative neoplasms

Reference Disease Frequency of SRSF2 mutation Effect on Survival Effect on disease progression
[8] CMML 28.4% NR NR
[42] CMML 47% (129/275) No No
[53] CMML 46% (173/409) NR NR
[41] CMML 40% (90/226) No No
[43] CMML 28% NR NR
[64] CMML 20% (1/5) NR NR
[26] CMML 32% (28/87) No NR
[77] CMML (Chinese population) 20% (10/50) No No
[45] CMML 44% (16/36) No NR
[57] CMML (aged < 65 years) 45% (72/161) Yes No
[58] CMML 25% (14/56) Yes Yes
[27] CMML 46% (143/312) Yes Yes
[56] CMML 40% (90/226) No No
[52] CMML 45% (116/274 NR No
[54] CMML 51% (74/146) NR NR
[67] CMML 53% (31/58) NR NR
  1. CMML Chronic Myelomonocytic Leukemia, NR not reported